Clinical Trial Update: Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports results from the RESPOND study evaluating infliximab (Remicade) in methotrexate-naïve psoriatic arthritis patients, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Psoriatic | Phase 3 | Status: COMPLETED | Results posted: 2009-07-07